Minute Insight: Insulet Acquires Insulin Pump Patents From Bigfoot, AGC
Insulet will acquire insulin pump patents from Bigfoot Biomedical for $25m, which Bigfoot will use to expand its Unity diabetes management system. Insulet also announced the acquisition of automated insulin delivery assets held by Automated Glucose Control.
You may also be interested in...
Bigfoot Looks To Unlock More Effective Treatments For Type II Diabetics
Bigfoot Biomedical’s Unity system pairs continuous glucose monitoring with smart insulin pen caps, giving patients recommendations on insulin dosing. Because patient interaction is involved, Bigfoot Biomedical can deliver insulin pump-like results to pump-ineligible type II diabetics.
Minute Insight: Insulet Launches Omnipod 5 US-Wide Following Trial Period
After six months, the Omnipod 5 has seen its limited market launch expanded to cover the entirety of the US market.
Medtronic Earns CE Mark For Affera Ablation System, Touts New PFA Results
Results of the PULSED AF trial confirm that Medtronic’s PulseSelect pulsed field ablation is safe and effective for atrial fibrillation ablation. The company will likely incorporate PulseSelect into its Affera cardiac mapping and ablation system, which will soon be available in Europe.